+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Laboratory Tests Market - Global Forecast 2026-2032- Product Image
Clinical Laboratory Tests Market - Global Forecast 2026-2032- Product Image
Sale

Clinical Laboratory Tests Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5311194
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Clinical Laboratory Tests Market is projected to reach USD 410.88 Billion in 2026. It is expected to continue growing at a CAGR of 5.73%, reaching USD 574.31 Billion by 2032.

Clinical laboratory tests remain the backbone of evidence-based medicine, informing screening, diagnosis, treatment selection, monitoring, and public health surveillance across hospitals, physician offices, reference laboratories, and point-of-care settings. From routine chemistry, hematology, microbiology, and immunoassay panels to molecular diagnostics, cytogenetics, pathology, and companion diagnostics, laboratory testing continues to guide a large share of clinical decisions.

Demand is being reinforced by aging populations, higher chronic disease prevalence, oncology and infectious disease testing needs, women’s health screening, transplant medicine, antimicrobial stewardship, and the shift toward precision medicine. Adoption is strongest where laboratories combine scalable automation, high-quality sample logistics, molecular diagnostics, and interoperable laboratory information systems with rigorous compliance under frameworks such as CLIA, ISO 15189, FDA oversight, and the EU In Vitro Diagnostic Regulation.

Transformative Shifts in Clinical Laboratory Testing

The clinical laboratory testing landscape is shifting from volume-centered chemistry and immunoassay workflows toward integrated diagnostic ecosystems that combine molecular testing, companion diagnostics, digital pathology, next-generation sequencing, syndromic infectious disease panels, and point-of-care platforms. Laboratories are increasingly expected to deliver faster turnaround times, traceable quality, clinically interpretable results, and seamless data exchange with electronic health records.

Regulatory expectations are also rising. The FDA’s 2024 final rule on laboratory-developed tests and Europe’s IVDR transition are increasing emphasis on analytical validity, clinical validity, traceability, post-market surveillance, and quality management. At the same time, hospital consolidation, reference lab scale, reimbursement scrutiny, supply chain pressure, and workforce shortages are accelerating automation, menu rationalization, remote validation, and distributed testing models.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative value across the testing cycle, from test ordering and specimen routing to image analysis, molecular variant interpretation, quality control, result prioritization, and clinical decision support. AI-enabled tools can reduce manual review burden and help laboratories identify anomalous results, pre-analytical errors, duplicate or low-value orders, and patterns that warrant faster clinician notification.

The strongest near-term impact is expected in workflow optimization rather than autonomous diagnosis. Adoption depends on validated algorithms, representative training data, bias assessment, cybersecurity, explainability, audit trails, and integration with LIS, EHR, and middleware platforms. Laboratories that treat AI as a regulated quality tool, not a stand-alone shortcut, are best positioned to improve turnaround time, consistency, operational resilience, and clinical utility.

Key Regional Insights for Clinical Laboratory Tests

North America leads in advanced clinical laboratory tests due to established reimbursement pathways, large reference laboratory networks, high use of molecular diagnostics, broad CLIA-based laboratory oversight, and strong regulatory infrastructure in the United States and Canada. Europe remains a quality-driven region shaped by IVDR implementation, national health systems, ISO-based accreditation, antimicrobial resistance surveillance, and strong adoption of oncology, prenatal, infectious disease, and chronic disease testing.

Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Australia, and ASEAN economies invest in hospital capacity, screening programs, digital health systems, and private diagnostics. Latin America, led by Brazil and Mexico, is improving access through private laboratory networks and public health programs, while the Middle East is investing in tertiary care, genomics, newborn screening, and medical tourism. Africa shows rising need for infectious disease, maternal health, tuberculosis, HIV, malaria, and chronic disease testing, with progress tied to infrastructure, supply chain reliability, accreditation, sample transport, and workforce development.

Key Group Insights Across Global Health Economies

The G7 markets set many global benchmarks for clinical laboratory test quality, reimbursement discipline, automation, accreditation, digital pathology, and regulatory science, while the European Union is defining one of the most influential compliance environments through IVDR, cross-border health data priorities, and coordinated health technology assessment initiatives. NATO economies benefit from resilient health infrastructure, emergency preparedness, and defense-linked biosurveillance priorities that support laboratory readiness and outbreak response capacity.

BRICS countries are central to future testing demand because of large populations, rising chronic disease burden, expanding hospital networks, and higher investment in domestic diagnostics manufacturing. ASEAN is gaining importance as a regional hub for affordable testing, private healthcare growth, medical travel, and cross-border laboratory services. GCC countries are investing in precision medicine, reference laboratories, genomic programs, and digital health infrastructure as part of healthcare diversification strategies and national transformation plans.

Key Country Insights in Clinical Laboratory Testing

The United States remains the most influential clinical laboratory testing environment, supported by CLIA-certified laboratories, large reference networks, FDA oversight, advanced molecular testing adoption, payer evidence requirements, and strong demand for oncology, infectious disease, and genetic testing. Canada emphasizes provincial reimbursement, quality assurance, public health laboratory coordination, and equitable access, while Mexico is expanding private diagnostics and chronic disease testing. Brazil anchors Latin America with a large private laboratory sector, public health testing demand, and expanding molecular diagnostics capabilities.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine mature healthcare systems with growing demand for oncology, infectious disease, preventive testing, prenatal screening, and antimicrobial resistance monitoring, while Russia maintains significant domestic laboratory capacity amid supply chain constraints and localization priorities. China and India are major growth engines due to population scale, hospital expansion, expanding insurance coverage, and rising demand for molecular and routine diagnostics. Japan, Australia, and South Korea stand out for quality systems, aging-related testing demand, digital health adoption, national screening programs, and advanced diagnostics infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize test menus with clear clinical utility, defensible reimbursement, strong analytical validation, and evidence packages aligned with payer, regulator, and clinician expectations. Investments in automation, sample tracking, middleware, cybersecurity, digital pathology, inventory controls, and interoperable LIS/EHR connectivity can improve throughput, reduce errors, and support scalable growth.

Organizations should prepare for tighter oversight of laboratory-developed tests by strengthening validation records, change control, post-market monitoring, complaint handling, proficiency testing, and supplier quality management. Partnerships with hospitals, payers, pharmaceutical developers, academic centers, and public health agencies can expand access to companion diagnostics, decentralized testing, disease surveillance, and population screening while maintaining compliance, data security, and patient trust.

Research Methodology

This executive summary is based on a structured review of public regulatory guidance, peer-reviewed literature, health agency publications, reimbursement documents, accreditation standards, clinical practice guidelines, and macroeconomic indicators from sources such as FDA, CDC, WHO, OECD, World Bank, European Commission, and national health authorities.

Insights are triangulated across demand drivers, technology adoption, regulatory changes, laboratory operations, workforce constraints, reimbursement trends, disease burden, and regional healthcare infrastructure. Qualitative assessment focuses on verifiable market signals rather than unsupported projections, with emphasis on clinical utility, regulatory readiness, operational quality, and commercially relevant adoption patterns.

Conclusion

Clinical laboratory tests are moving from transactional diagnostics toward integrated, data-enabled clinical decision platforms. The sector is being reshaped by molecular testing, AI-assisted workflows, point-of-care expansion, automation, digital pathology, stronger quality systems, and stricter evidence requirements.

Organizations that align innovation with quality systems, reimbursement evidence, regulatory compliance, cybersecurity, and regional access needs will be best positioned to support sustainable growth. The winners will be laboratories and diagnostic stakeholders that deliver accurate, timely, clinically actionable results at scale while maintaining trust, transparency, and measurable patient value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.1.1. Expanding Clinical Decision Dependence
4.3.1.2. Diverse and Recurring Care Demand
4.3.1.3. Workflow Automation and Analytical Innovation
4.3.2. Key Restraints
4.3.2.1. Reimbursement Pressure and Utilization Controls
4.3.2.2. Operational and Capability Constraints
4.3.3. Key Opportunities
4.3.3.1. Workflow Integration and Digital Enablement
4.3.3.2. Hybrid Centralized and Decentralized Delivery
4.3.4. Key Challenges
4.3.4.1. Regulatory and Evidence Complexity
4.3.4.2. Quality Governance Across Care Settings
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Clinical Laboratory Tests Market, by Commercial Offering
7.1. Introduction
7.2. Assays & Reagents
7.3. Laboratory Testing Services
7.4. Instruments & Automation Systems
7.5. Diagnostic Analysis Software
7.6. Calibrators & Controls
7.7. Specimen Receptacles & Preanalytical Products
8. Clinical Laboratory Tests Market, by Laboratory Discipline
8.1. Introduction
8.2. Clinical Chemistry & Toxicology
8.2.1. Clinical Chemistry
8.2.2. Toxicology
8.3. Immunology & Serology
8.4. Molecular & Cytogenetic Diagnostics
8.4.1. Molecular Diagnostics
8.4.2. Cytogenetics
8.5. Microbiology
8.5.1. Bacteriology
8.5.2. Virology
8.5.3. Mycobacteriology
8.5.4. Mycology
8.5.5. Parasitology
8.6. Hematology & Hemostasis
8.6.1. Cellular Hematology
8.6.2. Hemostasis & Coagulation
8.7. Anatomic Pathology
8.7.1. Histopathology
8.7.2. Cytology
8.8. Transfusion & Transplantation Testing
8.8.1. Immunohematology
8.8.2. Histocompatibility & Immunogenetics
9. Clinical Laboratory Tests Market, by Analytical Platform
9.1. Introduction
9.2. Chemical & Physical Measurement
9.2.1. Optical Spectroscopy
9.2.2. Electrochemical & Physical Sensing
9.2.3. Coagulometry
9.3. Immunochemical & Binding Analysis
9.3.1. Immunoassay
9.3.2. Agglutination & Precipitation
9.3.3. Immunoblot & Line Blot
9.4. Molecular & Genomic Analysis
9.4.1. Nucleic Acid Amplification
9.4.2. Sequencing
9.4.3. Genotyping & Microarray
9.4.4. Extracted Nucleic Acid Hybridization
9.5. Cellular & Morphologic Analysis
9.5.1. Automated Cell Counting
9.5.2. Flow Cytometry
9.5.3. Specimen Microscopy & Particle Imaging
9.5.4. Cell Function Assays
9.6. Culture & Phenotypic Microbiology
9.6.1. Culture & Growth Detection
9.6.2. Biochemical & Phenotypic Identification
9.6.3. Antimicrobial Susceptibility Testing
9.7. Tissue & Slide Analysis
9.7.1. Immunohistochemistry
9.7.2. Histochemical & Cytological Staining
9.7.3. Digital Pathology & Image Analysis
9.7.4. In Situ Hybridization
9.8. Separation & Mass Analysis
9.8.1. Chromatography
9.8.2. Electrophoresis
9.8.3. Mass Spectrometry
10. Clinical Laboratory Tests Market, by Clinical Purpose
10.1. Introduction
10.2. Diagnosis & Disease Classification
10.3. Physiological Status Assessment
10.4. Treatment Response & Disease Monitoring
10.5. Screening & Early Detection
10.6. Treatment Selection & Therapy Guidance
10.7. Prognosis & Staging
10.8. Compatibility, Donor & Transplant Assessment
10.9. Susceptibility & Risk Assessment
11. Clinical Laboratory Tests Market, by Specimen Type
11.1. Introduction
11.2. Blood & Blood Components
11.2.1. Whole Blood
11.2.2. Serum
11.2.3. Plasma
11.2.4. Cellular Blood Components & Blood Products
11.2.5. Dried Blood Spots
11.3. Urine
11.4. Tissue & Cellular Specimens
11.5. Respiratory Specimens
11.6. Reproductive & Prenatal Specimens
11.7. Fecal & Gastrointestinal Specimens
11.8. Surface, Lesion & Appendage Specimens
11.9. Serous, Synovial & Cavity Fluids
11.10. Cerebrospinal Fluid
11.11. Saliva & Oral Fluid
11.12. Breath & Exhaled Gas
12. Clinical Laboratory Tests Market, by Testing Setting
12.1. Introduction
12.2. Routine Clinical Laboratories
12.3. Specialized & Reference Laboratories
12.4. Acute-Care Point-of-Care Testing
12.5. Ambulatory & Primary-Care Point-of-Care Testing
12.6. Community & Outreach Testing
12.7. Home & Self-Testing
13. Clinical Laboratory Tests Market, by Commercialization Model
13.1. Introduction
13.2. Provider- & Institution-Ordered Laboratory Services
13.3. Distributed Professional-Use IVDs
13.4. Health-Institution In-House IVDs
13.5. Sponsor-Commissioned Clinical Trial Services
13.6. Consumer-Initiated Laboratory Services
13.7. Distributed Self-Test IVDs
14. Clinical Laboratory Tests Market, by Clinical Application
14.1. Introduction
14.2. Infectious Diseases
14.3. Endocrine, Metabolic & Nutritional Disorders
14.4. Oncology
14.5. Routine Health & Preventive Care
14.6. Hematologic & Coagulation Disorders
14.7. Reproductive, Maternal & Newborn Health
14.8. Cardiovascular Disorders
14.9. Gastrointestinal, Hepatic & Pancreatic Disorders
14.10. Renal & Urologic Disorders
14.11. Respiratory Disorders
14.12. Neurologic, Psychiatric & Sensory Disorders
14.13. Immune Disorders & Allergy
14.14. Genetic & Congenital Disorders
14.15. Musculoskeletal, Connective Tissue & Skin Disorders
14.16. Toxicology & Therapeutic Drug Monitoring
14.17. Transfusion & Transplantation
15. Clinical Laboratory Tests Market, by Buyer Type
15.1. Introduction
15.2. Hospitals & Health Systems
15.3. Independent & Reference Laboratories
15.4. Ambulatory & Community Care Providers
15.5. Public Health Agencies & Government Programs
15.6. Blood Services & Transplant Organizations
15.7. Clinical Trial Sponsors
15.8. Consumers & Patients
16. Clinical Laboratory Tests Market, by Region
16.1. Introduction
16.2. North America
16.3. Europe
16.4. Asia-Pacific
16.5. Latin America
16.6. Middle East
16.7. Africa
17. Clinical Laboratory Tests Market, by Group
17.1. Introduction
17.2. NATO
17.3. G7
17.4. European Union
17.5. BRICS
17.6. ASEAN
17.7. GCC
18. Clinical Laboratory Tests Market, by Country
18.1. Introduction
18.2. United States
18.3. China
18.4. Japan
18.5. Germany
18.6. Canada
18.7. France
18.8. United Kingdom
18.9. India
18.10. Italy
18.11. Brazil
18.12. Australia
18.13. Spain
18.14. Mexico
18.15. South Korea
18.16. Russia
19. Competitive Landscape
19.1. Market Share Analysis, 2025
19.2. Market Concentration Analysis, 2025
19.2.1. Concentration Ratio (CR)
19.2.2. Herfindahl Hirschman Index (HHI)
19.3. Recent Developments & Impact Analysis, 2025
19.4. Product Portfolio Analysis, 2025
19.5. Benchmarking Analysis, 2025
20. Company Profiles
20.1. Abbott Laboratories
20.2. Roche Holding Ltd
20.3. Danaher Corporation
20.4. Siemens Healthineers AG
20.5. Thermo Fisher Scientific Inc.
20.6. Waters Corporation
20.7. bioMérieux SA
20.8. Sysmex Corporation
20.9. Bio-Rad Laboratories, Inc.
20.10. QIAGEN N.V.
20.11. Hologic, Inc.
20.12. QuidelOrtho Corporation
20.13. DiaSorin S.p.A.
20.14. Werfen, S.A.
20.15. Revvity, Inc.
20.16. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
20.17. HORIBA, Ltd.
20.18. Randox Laboratories Limited
20.19. H.U. Group Holdings, Inc.
20.20. Labcorp Holdings Inc.
20.21. Quest Diagnostics Incorporated
20.22. Sonic Healthcare Limited
20.23. Eurofins Scientific SE
20.24. Cerba HealthCare
20.25. Mayo Clinic Laboratories
20.26. ARUP Laboratories
20.27. Diagnósticos da América S.A.
20.28. Fleury S.A.
20.29. Grupo Diagnóstico Médico PROA, S.A. de C.V.
20.30. Unilabs
20.31. BIOGROUP
20.32. Groupe INOVIE
20.33. Limbach Gruppe SE
20.34. amedes Holding GmbH
20.35. Medicover AB
20.36. Diagnostyka S.A.
20.37. Dr. Lal PathLabs Limited
20.38. Metropolis Healthcare Limited
20.39. Vijaya Diagnostic Centre Limited
20.40. Neuberg Diagnostics Private Limited
20.41. Guangzhou KingMed Diagnostics Group Co., Ltd.
20.42. DIAN Diagnostics Group Co., Ltd.
20.43. ADICON Holdings Limited
20.44. BML, Inc.
20.45. GC Labs
20.46. Illumina, Inc.
20.47. Guardant Health, Inc.
20.48. Natera, Inc.
20.49. Myriad Genetics, Inc.
20.50. GeneDx Holdings Corp.
20.51. Tempus AI, Inc.
20.52. NeoGenomics, Inc.
20.53. GRAIL, Inc.
20.54. Adaptive Biotechnologies Corporation
20.55. Veracyte, Inc.
20.56. Agilent Technologies, Inc.
20.57. Bruker Corporation
20.58. Seegene, Inc.
20.59. TOSOH Corporation
20.60. Sebia
20.61. Shenzhen New Industries Biomedical Engineering Co., Ltd.
20.62. Autobio Diagnostics Co., Ltd.
20.63. Nova Biomedical
20.64. EKF Diagnostics Holdings plc
20.65. Molbio Diagnostics Limited
20.66. Al Borg Diagnostics
20.67. PathCare
21. Key Experts
List of Figures
FIGURE 1. Global Clinical Laboratory Tests Market, Years Considered for the Study
FIGURE 2. Global Clinical Laboratory Tests Market, Research Design
FIGURE 3. Global Clinical Laboratory Tests Market, Research Framework
FIGURE 4. Global Clinical Laboratory Tests Market, Data Triangulation
FIGURE 5. Global Clinical Laboratory Tests Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Clinical Laboratory Tests Market Size, by Commercial Offering, 2025 vs 2032 (%)
FIGURE 7. Global Clinical Laboratory Tests Market Size, by Commercial Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Clinical Laboratory Tests Market Size, by Laboratory Discipline, 2025 vs 2032 (%)
FIGURE 9. Global Clinical Laboratory Tests Market Size, by Laboratory Discipline, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Clinical Laboratory Tests Market Size, by Analytical Platform, 2025 vs 2032 (%)
FIGURE 11. Global Clinical Laboratory Tests Market Size, by Analytical Platform, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Clinical Laboratory Tests Market Size, by Clinical Purpose, 2025 vs 2032 (%)
FIGURE 13. Global Clinical Laboratory Tests Market Size, by Clinical Purpose, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Clinical Laboratory Tests Market Size, by Specimen Type, 2025 vs 2032 (%)
FIGURE 15. Global Clinical Laboratory Tests Market Size, by Specimen Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Clinical Laboratory Tests Market Size, by Testing Setting, 2025 vs 2032 (%)
FIGURE 17. Global Clinical Laboratory Tests Market Size, by Testing Setting, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Clinical Laboratory Tests Market Size, by Commercialization Model, 2025 vs 2032 (%)
FIGURE 19. Global Clinical Laboratory Tests Market Size, by Commercialization Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Clinical Laboratory Tests Market Size, by Clinical Application, 2025 vs 2032 (%)
FIGURE 21. Global Clinical Laboratory Tests Market Size, by Clinical Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Clinical Laboratory Tests Market Size, by Buyer Type, 2025 vs 2032 (%)
FIGURE 23. Global Clinical Laboratory Tests Market Size, by Buyer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Clinical Laboratory Tests Market Size, by Region, 2025 vs 2032 (%)
FIGURE 25. Global Clinical Laboratory Tests Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 26. Global Clinical Laboratory Tests Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Clinical Laboratory Tests Market Size, by Country, 2025 vs 2032 (%)
FIGURE 28. Global Clinical Laboratory Tests Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 29. Global Clinical Laboratory Tests Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Clinical Laboratory Tests Market Segmentation & Coverage
TABLE 2. Global Clinical Laboratory Tests Market Size, 2017-2032 (USD Million)
TABLE 3. Global Clinical Laboratory Tests Market Size, by Commercial Offering, 2017-2032 (USD Million)
TABLE 4. Global Assays & Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Assays & Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Assays & Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Laboratory Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Laboratory Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Laboratory Testing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Instruments & Automation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Instruments & Automation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Instruments & Automation Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Diagnostic Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Diagnostic Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Diagnostic Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Calibrators & Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Calibrators & Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Calibrators & Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Specimen Receptacles & Preanalytical Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Specimen Receptacles & Preanalytical Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Specimen Receptacles & Preanalytical Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Clinical Laboratory Tests Market Size, by Laboratory Discipline, 2017-2032 (USD Million)
TABLE 23. Global Clinical Chemistry & Toxicology Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Clinical Chemistry & Toxicology Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Clinical Chemistry & Toxicology Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Clinical Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Clinical Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Clinical Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Toxicology Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Toxicology Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Toxicology Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Immunology & Serology Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Immunology & Serology Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Immunology & Serology Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Molecular & Cytogenetic Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Molecular & Cytogenetic Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Molecular & Cytogenetic Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Cytogenetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Cytogenetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Cytogenetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Microbiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Microbiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Microbiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Bacteriology Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Bacteriology Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Bacteriology Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Virology Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Virology Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Virology Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Mycobacteriology Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Mycobacteriology Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Mycobacteriology Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Mycology Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Mycology Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Mycology Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Parasitology Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Parasitology Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Parasitology Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Hematology & Hemostasis Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Hematology & Hemostasis Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Hematology & Hemostasis Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Cellular Hematology Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Cellular Hematology Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Cellular Hematology Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Hemostasis & Coagulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Hemostasis & Coagulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Hemostasis & Coagulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Anatomic Pathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Anatomic Pathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Anatomic Pathology Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Histopathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Histopathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Histopathology Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Cytology Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Cytology Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Cytology Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Transfusion & Transplantation Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Transfusion & Transplantation Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Transfusion & Transplantation Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Immunohematology Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Immunohematology Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Immunohematology Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Histocompatibility & Immunogenetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Histocompatibility & Immunogenetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Histocompatibility & Immunogenetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Clinical Laboratory Tests Market Size, by Analytical Platform, 2017-2032 (USD Million)
TABLE 90. Global Chemical & Physical Measurement Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Chemical & Physical Measurement Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Chemical & Physical Measurement Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Optical Spectroscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Optical Spectroscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Optical Spectroscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Electrochemical & Physical Sensing Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Electrochemical & Physical Sensing Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Electrochemical & Physical Sensing Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Coagulometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Coagulometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Coagulometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Immunochemical & Binding Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Immunochemical & Binding Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Immunochemical & Binding Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Agglutination & Precipitation Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Agglutination & Precipitation Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Agglutination & Precipitation Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Immunoblot & Line Blot Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Immunoblot & Line Blot Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Immunoblot & Line Blot Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Molecular & Genomic Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Molecular & Genomic Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Molecular & Genomic Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Nucleic Acid Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Nucleic Acid Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Nucleic Acid Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Genotyping & Microarray Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Genotyping & Microarray Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Genotyping & Microarray Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Extracted Nucleic Acid Hybridization Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Extracted Nucleic Acid Hybridization Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Extracted Nucleic Acid Hybridization Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Cellular & Morphologic Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Cellular & Morphologic Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Cellular & Morphologic Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Automated Cell Counting Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Automated Cell Counting Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Automated Cell Counting Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Specimen Microscopy & Particle Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Specimen Microscopy & Particle Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Specimen Microscopy & Particle Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Cell Function Assays Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Cell Function Assays Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Cell Function Assays Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Culture & Phenotypic Microbiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Culture & Phenotypic Microbiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Culture & Phenotypic Microbiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Culture & Growth Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Culture & Growth Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Culture & Growth Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Biochemical & Phenotypic Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Biochemical & Phenotypic Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Biochemical & Phenotypic Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Antimicrobial Susceptibility Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 154. Global Antimicrobial Susceptibility Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. Global Antimicrobial Susceptibility Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 156. Global Tissue & Slide Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Global Tissue & Slide Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. Global Tissue & Slide Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. Global Immunohistochemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 160. Global Immunohistochemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 161. Global Immunohistochemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 162. Global Histochemical & Cytological Staining Market Size, by Region, 2017-2032 (USD Million)
TABLE 163. Global Histochemical & Cytological Staining Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. Global Histochemical & Cytological Staining Market Size, by Country, 2017-2032 (USD Million)
TABLE 165. Global Digital Pathology & Image Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Global Digital Pathology & Image Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. Global Digital Pathology & Image Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 168. Global In Situ Hybridization Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Global In Situ Hybridization Market Size, by Group, 2017-2032 (USD Million)
TABLE 170. Global In Situ Hybridization Market Size, by Country, 2017-2032 (USD Million)
TABLE 171. Global Separation & Mass Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 172. Global Separation & Mass Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. Global Separation & Mass Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 174. Global Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. Global Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. Global Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 177. Global Electrophoresis Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Global Electrophoresis Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. Global Electrophoresis Market Size, by Country, 2017-2032 (USD Million)
TABLE 180. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 183. Global Clinical Laboratory Tests Market Size, by Clinical Purpose, 2017-2032 (USD Million)
TABLE 184. Global Diagnosis & Disease Classification Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Global Diagnosis & Disease Classification Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. Global Diagnosis & Disease Classification Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. Global Physiological Status Assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Global Physiological Status Assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. Global Physiological Status Assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 190. Global Treatment Response & Disease Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Global Treatment Response & Disease Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. Global Treatment Response & Disease Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. Global Screening & Early Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Global Screening & Early Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. Global Screening & Early Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 196. Global Treatment Selection & Therapy Guidance Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Global Treatment Selection & Therapy Guidance Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. Global Treatment Selection & Therapy Guidance Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. Global Prognosis & Staging Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Global Prognosis & Staging Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. Global Prognosis & Staging Market Size, by Country, 2017-2032 (USD Million)
TABLE 202. Global Compatibility, Donor & Transplant Assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Global Compatibility, Donor & Transplant Assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. Global Compatibility, Donor & Transplant Assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. Global Susceptibility & Risk Assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 206. Global Susceptibility & Risk Assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 207. Global Susceptibility & Risk Assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 208. Global Clinical Laboratory Tests Market Size, by Specimen Type, 2017-2032 (USD Million)
TABLE 209. Global Blood & Blood Components Market Size, by Region, 2017-2032 (USD Million)
TABLE 210. Global Blood & Blood Components Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. Global Blood & Blood Components Market Size, by Country, 2017-2032 (USD Million)
TABLE 212. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 215. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 216. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 218. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 221. Global Cellular Blood Components & Blood Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 222. Global Cellular Blood Components & Blood Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. Global Cellular Blood Components & Blood Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 224. Global Dried Blood Spots Market Size, by Region, 2017-2032 (USD Million)
TABLE 225. Global Dried Blood Spots Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. Global Dried Blood Spots Market Size, by Country, 2017-2032 (USD Million)
TABLE 227. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 230. Global Tissue & Cellular Specimens Market Size, by Region, 2017-2032 (USD Million)
TABLE 231. Global Tissue & Cellular Specimens Market Size, by Group, 2017-2032 (USD Million)
TABLE 232. Global Tissue & Cellular Specimens Market Size, by Country, 2017-2032 (USD Million)
TABLE 233. Global Respiratory Specimens Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. Global Respiratory Specimens Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. Global Respiratory Specimens Market Size, by Country, 2017-2032 (USD Million)
TABLE 236. Global Reproductive & Prenatal Specimens Market Size, by Region, 2017-2032 (USD Million)
TABLE 237. Global Reproductive & Prenatal Specimens Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. Global Reproductive & Prenatal Specimens Market Size, by Country, 2017-2032 (USD Million)
TABLE 239. Global Fecal & Gastrointestinal Specimens Market Size, by Region, 2017-2032 (USD Million)
TABLE 240. Global Fecal & Gastrointestinal Specimens Market Size, by Group, 2017-2032 (USD Million)
TABLE 241. Global Fecal & Gastrointestinal Specimens Market Size, by Country, 2017-2032 (USD Million)
TABLE 242. Global Surface, Lesion & Appendage Specimens Market Size, by Region, 2017-2032 (USD Million)
TABLE 243. Global Surface, Lesion & Appendage Specimens Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. Global Surface, Lesion & Appendage Specimens Market Size, by Country, 2017-2032 (USD Million)
TABLE 245. Global Serous, Synovial & Cavity Fluids Market Size, by Region, 2017-2032 (USD Million)
TABLE 246. Global Serous, Synovial & Cavity Fluids Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. Global Serous, Synovial & Cavity Fluids Market Size, by Country, 2017-2032 (USD Million)
TABLE 248. Global Cerebrospinal Fluid Market Size, by Region, 2017-2032 (USD Million)
TABLE 249. Global Cerebrospinal Fluid Market Size, by Group, 2017-2032 (USD Million)
TABLE 250. Global Cerebrospinal Fluid Market Size, by Country, 2017-2032 (USD Million)
TABLE 251. Global Saliva & Oral Fluid Market Size, by Region, 2017-2032 (USD Million)
TABLE 252. Global Saliva & Oral Fluid Market Size, by Group, 2017-2032 (USD Million)
TABLE 253. Global Saliva & Oral Fluid Market Size, by Country, 2017-2032 (USD Million)
TABLE 254. Global Breath & Exhaled Gas Market Size, by Region, 2017-2032 (USD Million)
TABLE 255. Global Breath & Exhaled Gas Market Size, by Group, 2017-2032 (USD Million)
TABLE 256. Global Breath & Exhaled Gas Market Size, by Country, 2017-2032 (USD Million)
TABLE 257. Global Clinical Laboratory Tests Market Size, by Testing Setting, 2017-2032 (USD Million)
TABLE 258. Global Routine Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 259. Global Routine Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 260. Global Routine Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 261. Global Specialized & Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 262. Global Specialized & Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 263. Global Specialized & Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 264. Global Acute-Care Point-of-Care Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 265. Global Acute-Care Point-of-Care Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 266. Global Acute-Care Point-of-Care Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 267. Global Ambulatory & Primary-Care Point-of-Care Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 268. Global Ambulatory & Primary-Care Point-of-Care Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 269. Global Ambulatory & Primary-Care Point-of-Care Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 270. Global Community & Outreach Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 271. Global Community & Outreach Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. Global Community & Outreach Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 273. Global Home & Self-Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 274. Global Home & Self-Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 275. Global Home & Self-Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 276. Global Clinical Laboratory Tests Market Size, by Commercialization Model, 2017-2032 (USD Million)
TABLE 277. Global Provider- & Institution-Ordered Laboratory Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 278. Global Provider- & Institution-Ordered Laboratory Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 279. Global Provider- & Institution-Ordered Laboratory Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 280. Global Distributed Professional-Use IVDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 281. Global Distributed Professional-Use IVDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 282. Global Distributed Professional-Use IVDs Market Size, by Country, 2017-2032 (USD Million)
TABLE 283. Global Health-Institution In-House IVDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 284. Global Health-Institution In-House IVDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 285. Global Health-Institution In-House IVDs Market Size, by Country, 2017-2032 (USD Million)
TABLE 286. Global Sponsor-Commissioned Clinical Trial Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 287. Global Sponsor-Commissioned Clinical Trial Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 288. Global Sponsor-Commissioned Clinical Trial Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 289. Global Consumer-Initiated Laboratory Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 290. Global Consumer-Initiated Laboratory Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 291. Global Consumer-Initiated Laboratory Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 292. Global Distributed Self-Test IVDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 293. Global Distributed Self-Test IVDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. Global Distributed Self-Test IVDs Market Size, by Country, 2017-2032 (USD Million)
TABLE 295. Global Clinical Laboratory Tests Market Size, by Clinical Application, 2017-2032 (USD Million)
TABLE 296. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 297. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 298. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 299. Global Endocrine, Metabolic & Nutritional Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 300. Global Endocrine, Metabolic & Nutritional Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 301. Global Endocrine, Metabolic & Nutritional Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 302. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 303. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 304. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 305. Global Routine Health & Preventive Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 306. Global Routine Health & Preventive Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 307. Global Routine Health & Preventive Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 308. Global Hematologic & Coagulation Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 309. Global Hematologic & Coagulation Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 310. Global Hematologic & Coagulation Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 311. Global Reproductive, Maternal & Newborn Health Market Size, by Region, 2017-2032 (USD Million)
TABLE 312. Global Reproductive, Maternal & Newborn Health Market Size, by Group, 2017-2032 (USD Million)
TABLE 313. Global Reproductive, Maternal & Newborn Health Market Size, by Country, 2017-2032 (USD Million)
TABLE 314. Global Cardiovascular Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 315. Global Cardiovascular Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 316. Global Cardiovascular Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 317. Global Gastrointestinal, Hepatic & Pancreatic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 318. Global Gastrointestinal, Hepatic & Pancreatic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 319. Global Gastrointestinal, Hepatic & Pancreatic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 320. Global Renal & Urologic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 321. Global Renal & Urologic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 322. Global Renal & Urologic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 323. Global Respiratory Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 324. Global Respiratory Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 325. Global Respiratory Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 326. Global Neurologic, Psychiatric & Sensory Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 327. Global Neurologic, Psychiatric & Sensory Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 328. Global Neurologic, Psychiatric & Sensory Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 329. Global Immune Disorders & Allergy Market Size, by Region, 2017-2032 (USD Million)
TABLE 330. Global Immune Disorders & Allergy Market Size, by Group, 2017-2032 (USD Million)
TABLE 331. Global Immune Disorders & Allergy Market Size, by Country, 2017-2032 (USD Million)
TABLE 332. Global Genetic & Congenital Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 333. Global Genetic & Congenital Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 334. Global Genetic & Congenital Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 335. Global Musculoskeletal, Connective Tissue & Skin Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 336. Global Musculoskeletal, Connective Tissue & Skin Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 337. Global Musculoskeletal, Connective Tissue & Skin Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 338. Global Toxicology & Therapeutic Drug Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 339. Global Toxicology & Therapeutic Drug Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 340. Global Toxicology & Therapeutic Drug Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 341. Global Transfusion & Transplantation Market Size, by Region, 2017-2032 (USD Million)
TABLE 342. Global Transfusion & Transplantation Market Size, by Group, 2017-2032 (USD Million)
TABLE 343. Global Transfusion & Transplantation Market Size, by Country, 2017-2032 (USD Million)
TABLE 344. Global Clinical Laboratory Tests Market Size, by Buyer Type, 2017-2032 (USD Million)
TABLE 345. Global Hospitals & Health Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 346. Global Hospitals & Health Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 347. Global Hospitals & Health Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 348. Global Independent & Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 349. Global Independent & Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 350. Global Independent & Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 351. Global Ambulatory & Community Care Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 352. Global Ambulatory & Community Care Providers Mark

Companies Mentioned

  • Abbott Laboratories
  • Roche Holding Ltd
  • Danaher Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
  • bioMérieux SA
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Hologic, Inc.
  • QuidelOrtho Corporation
  • DiaSorin S.p.A.
  • Werfen, S.A.
  • Revvity, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • HORIBA, Ltd.
  • Randox Laboratories Limited
  • H.U. Group Holdings, Inc.
  • Labcorp Holdings Inc.
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • Eurofins Scientific SE
  • Cerba HealthCare
  • Mayo Clinic Laboratories
  • ARUP Laboratories
  • Diagnósticos da América S.A.
  • Fleury S.A.
  • Grupo Diagnóstico Médico PROA, S.A. de C.V.
  • Unilabs
  • BIOGROUP
  • Groupe INOVIE
  • Limbach Gruppe SE
  • amedes Holding GmbH
  • Medicover AB
  • Diagnostyka S.A.
  • Dr. Lal PathLabs Limited
  • Metropolis Healthcare Limited
  • Vijaya Diagnostic Centre Limited
  • Neuberg Diagnostics Private Limited
  • Guangzhou KingMed Diagnostics Group Co., Ltd.
  • DIAN Diagnostics Group Co., Ltd.
  • ADICON Holdings Limited
  • BML, Inc.
  • GC Labs
  • Illumina, Inc.
  • Guardant Health, Inc.
  • Natera, Inc.
  • Myriad Genetics, Inc.
  • GeneDx Holdings Corp.
  • Tempus AI, Inc.
  • NeoGenomics, Inc.
  • GRAIL, Inc.
  • Adaptive Biotechnologies Corporation
  • Veracyte, Inc.
  • Agilent Technologies, Inc.
  • Bruker Corporation
  • Seegene, Inc.
  • TOSOH Corporation
  • Sebia
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Autobio Diagnostics Co., Ltd.
  • Nova Biomedical
  • EKF Diagnostics Holdings plc
  • Molbio Diagnostics Limited
  • Al Borg Diagnostics
  • PathCare

Table Information

Report AttributeDetails
No. of Pages182
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 410.88 Billion
Forecasted Market Value ( USD ) by 2032 $ 574.31 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned67

Related Topics

Related Reports

Clinical Laboratory Services Market - Global Forecast 2026-2032 - Product Image

Clinical Laboratory Services Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Next Generation Sequencing CLIA Laboratory Services Market - Global Forecast 2026-2032 - Product Image

Next Generation Sequencing CLIA Laboratory Services Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Laboratory Developed Tests - Global Strategic Business Report - Product Image

Laboratory Developed Tests - Global Strategic Business Report

  • Report
  • 317 Pages
  • Global
From
Clinical Reference Laboratory - Global Strategic Business Report - Product Image

Clinical Reference Laboratory - Global Strategic Business Report

  • Report
  • 266 Pages
  • Global
From
Clinical Laboratory Services - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Clinical Laboratory Services - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.